Biomimetic nanovaccine-mediated multivalent IL-15 self-transpresentation (MIST) for potent and safe cancer immunotherapyKaiyuan Wang(Shenyang Pharmaceutical University), Jin Sun(Shenyang Pharmaceutical University)Nature CommunicationsOctober 24, 202310.1038/s41467-023-42155-zCited by 70SaveCiteExport RISWatch citationsRelated PapersGas therapy potentiates aggregation-induced emission luminogen-based photoimmunotherapy of poorly immunogenic tumors through cGAS-STING pathway activation|Nature Communications|2023|240Promising alternatives of CD47 monoclonal antibody: an injectable degradable hydrogel loaded with PQ912 for postoperative immunotherapy effectively blocks CD47-SIRPα signal|Theranostics|2022|15